www.alldocs.info « cancers »
by www.alldocs.info
the most recent document references on :: cancers
Google
 
 Web   cancers.alldocs.info 
 
    Languages: malattie oncologiche  cancers  cancer  cancer  Krebse          Found 1931 documents         Page 8 of 65   Pages:  <<  <  3  4  5  6  7  8  9  10  11  12  13  >  >> 
 
 
 
   cancers cancers
     bladder cancer bladder cancer
     brain cancer brain cancer
     breast cancer breast cancer
     colon cancer colon cancer
     gastrointestinal cancer gastrointestinal cancer
     kidney cancer kidney cancer
     laryngeal cancer laryngeal cancer
     leukaemia leukaemia
     liver cancer liver cancer
     lung cancer lung cancer
     lymphoma lymphoma
     myeloma myeloma
     neuroblastoma neuroblastoma
     ovarian cancer ovarian cancer
     pancreatic cancer pancreatic cancer
     prostate cancer prostate cancer
     stomach cancer stomach cancer
     testicular cancer testicular cancer
     thyroid cancer thyroid cancer
     uterine cancer uterine cancer
     prevention prevention
     diagnosis diagnosis
     therapies therapies
  cancers.alldocs.infohomepage
www.alldocs.infowww.alldocs.info


 

  Legenda: last week last month

  [211] SEER Cancer Statistics Review 1975-2002 National Cancer Institute
      PDF [111,8 KB]  From [seer.cancer.gov]  Last viewed: 07.09.2006
SEER Cancer Statistics Review 1975-2002 National Cancer Institute Joinpoint Regression Program Version 3.0, April 2005, National Cancer Institute. ( h ttp://srab. cancer .gov/joinpoint/ ). The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130). a Trends are from the SEER 9 areas. b Trends are from the NCHS public use data file for the total US. c The APC is significantly different from zero (p<.05). Joinpoint Segment 1 Joinpoint Segment 2 Joinpoint Segment 3 Joinpoint Segment 4 Year APC Year APC Year APC Year APC SEER Cancer Incidence a All Races Male and Female 1975-1987 0.8 c 1987-1996 -0.2 1996-2000 1.2 2000-2002 -2.5 All Races Male 1975-1987 1.0 c ...

  [212] SEER Cancer Statistics Review 1973-1999 National Cancer Institute
      PDF [66,3 KB]  From [seer.cancer.gov]  Last viewed: 07.09.2006
The APC is the Annual Percent Change based on rates age-adjusted to the 2000 U.S. standard population by 5-year age groups using the Joinpoint Regression Program. a Trends are from the SEER 9 areas. b Trends are from the NCHS public use data file. ’ The APC is significantly different from zero (p<.05). Table XX-1 OVARY CANCER (Invasive) TRENDS IN SEER INCIDENCE a AND U.S. MORTALITY b USING THE JOINPOINT REGRESSION PROGRAM, 1973-1999 WITH UP TO THREE JOINPOINTS BY RACE AND AGE All Races Whites Blacks Year APC Year APC Year APC SEER Cancer Incidence a Age - All Ages 1973-86 -0.3 1973-86 -0.2 1973-99 0.4 1986-89 5.0 1986-89 5.4 1989-99 -0.7 ’ 1989-99 -0.7 ’ Age - Under 65 1973-86 -1.2 ’ 1973-82 ...

  [213] SEER Cancer Statistics Review 1973-1999 National Cancer Institute
      PDF [83,8 KB]  From [seer.cancer.gov]  Last viewed: 07.09.2006
The APC is the Annual Percent Change based on rates age-adjusted to the 2000 U.S. standard population by 5-year age groups using the Joinpoint Regression Program. a Trends are from the SEER 9 areas. b Trends are from the NCHS public use data file. ’ The APC is significantly different from zero (p<.05). Table XVI-1 MELANOMA OF SKIN (Invasive) TRENDS IN SEER INCIDENCE a AND U.S. MORTALITY b USING THE JOINPOINT REGRESSION PROGRAM, 1973-1999 WITH UP TO THREE JOINPOINTS BY RACE AND SEX All Races Whites Blacks Year APC Year APC Year APC SEER Cancer Incidence a Sex - Male and Female 1973-81 6.1 ’ 1973-81 6.5 ’ 1973-99 0.7 1981-99 2.8 ’ 1981-99 3.0 ’ Sex - Male 1973-85 5.7 ’ 1973-85 6.0 ’ 1973-99 2.8 ...

  [214] Cancer Statistics Review
      PDF [19,4 KB]  From [seer.cancer.gov]  Last viewed: 07.09.2006
SEER Cancer Statistics Review 1975-2001 National Cancer Institute Note: Incidence and death rates are per 100,000 and are age-adjusted to the 2000 U.S. standard population by 5-year age groups. Survival rates are expressed as percents. a SEER 12 areas. b NCHS public use data file for the total US. c SEER 9 areas. - Statistic could not be calculated due to less than 25 cases in the time interval. Incidence a US Mortality b Survival c (1997-2001) (1997-2001) (1995-2000) Site Total Males Females Total Males Females Total Males Females All Sites 470.3 554.3 414.4 199.8 251.1 166.7 64.1 64.0 64.3 Oral Cavity & Pharynx: 10.7 15.7 6.4 2.8 4.3 1.6 58.7 57.4 61.5 Lip 1.0 1.7 ...

  [215] SEER Cancer Statistics Review 1975-2001 National Cancer Institute
      PDF [198,1 KB]  From [seer.cancer.gov]  Last viewed: 07.09.2006
SEER Cancer Statistics Review 1975-2001 National Cancer Institute Joinpoint Regression Program Version 2.7, September 2003, National Cancer Institute. ( h ttp://srab. cancer .gov/joinpoint/ ). The APC is the Annual Percent Change based on rates age-adjusted to the 2000 U.S. standard population by 5-year age groups. a Trends are from the SEER 9 areas. b Trends are from the NCHS public use data file for the total US. c The APC is significantly different from zero (p<.05). Joinpoint Segment 1 Joinpoint Segment 2 Joinpoint Segment 3 Joinpoint Segment 4 Year APC Year APC Year APC Year APC SEER Cancer Incidence a All Races All Ages 1975-1980 -0.4 1980-1987 3.7 c 1987-2001 0.4 c All Races Under 50 1975-1980 -1.4 1980-1986 2.9 ...

  [216] Cancer Statistics Review
      PDF [7,3 KB]  From [seer.cancer.gov]  Last viewed: 07.09.2006
SEER Cancer Statistics Review 1975-2002 National Cancer Institute Devcan Version 6.0, April 2005, National Cancer Institute ( h ttp://srab. cancer .gov/devcan/ ). Source: SEER 13 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia). Note: Invasive cancer only unless specified otherwise. All Races Whites Blacks Site Males Females Males Females Males Females All Sites 45.67 38.09 46.11 39.45 42.50 31.88 Invasive and In Situ 46.91 41.44 47.48 42.99 42.79 33.99 Oral cavity and Pharynx 1.38 0.68 1.40 0.70 1.29 0.50 Esophagus 0.76 0.25 0.78 0.24 0.77 0.34 Stomach 1.22 0.75 1.06 0.61 1.27 0.97 Colon and ...

  [217] SEER Cancer Statistics Review 1973-1999 National Cancer Institute
      PDF [98,6 KB]  From [seer.cancer.gov]  Last viewed: 07.09.2006
The APC is the Annual Percent Change based on rates age-adjusted to the 2000 U.S. standard population by 5-year age groups using the Joinpoint Regression Program. a Trends are from the SEER 9 areas. b Trends are from the NCHS public use data file. ’ The APC is significantly different from zero (p<.05). Table VI-1 COLON AND RECTUM CANCER (Invasive) TRENDS IN SEER INCIDENCE a AND U.S. MORTALITY b USING THE JOINPOINT REGRESSION PROGRAM, 1973-1999 WITH UP TO THREE JOINPOINTS BY RACE AND SEX All Races Whites Blacks Year APC Year APC Year APC SEER Cancer Incidence a Sex - Male and Female 1973-85 0.9 ’ 1973-85 0.9 ’ 1973-80 3.6 ’ 1985-95 -1.8 ’ 1985-95 -1.9 ’ 1980-99 -0.3 1995-99 0.3 1995-99 0.3 Sex - ...

  [218] SEER Cancer Statistics Review 1973-1999 National Cancer Institute
      PDF [85,7 KB]  From [seer.cancer.gov]  Last viewed: 07.09.2006
The APC is the Annual Percent Change based on rates age-adjusted to the 2000 U.S. standard population by 5-year age groups using the Joinpoint Regression Program. a Trends are from the SEER 9 areas. b Trends are from the NCHS public use data file. ’ The APC is significantly different from zero (p<.05). Table XXII-1 PROSTATE CANCER (Invasive) TRENDS IN SEER INCIDENCE a AND U.S. MORTALITY b USING THE JOINPOINT REGRESSION PROGRAM, 1973-1999 WITH UP TO THREE JOINPOINTS BY RACE AND AGE All Races Whites Blacks Year APC Year APC Year APC SEER Cancer Incidence a Age - All Ages 1973-88 2.7 ’ 1973-88 2.8 ’ 1973-89 2.1 ’ 1988-92 16.2 ’ 1988-92 16.1 ’ 1989-92 20.6 ’ 1992-95 -11.7 ’ 1992-95 -12.8 ’ 1992-96 ...

  [219] 2005 State of the State of Gynecologic Cancers
      PDF [521,3 KB]  From [www.thegcf.org]  Last viewed: 07.09.2006
2005 State of the State of Gynecologic Cancers Third Annual Report to the Women of America Page 2 About the Society of Gynecologic Oncologists and the Gynecologic Cancer Foundation The Society of Gynecologic Oncologists (SGO) is a national medical specialty organization of physicians who are trained in the comprehensive management of women with female repro- ductive cancers . Gynecologic oncologists are obstetricians-gynecologists with an additional three to four years of training. SGO’s purpose is to improve the care of women with gynecologic can- cer by encouraging research, disseminating knowledge to raise the standards of practice in the treatment and prevention of gynecologic malignancies, and cooperating with other organizations interested in women’s health care, oncology and related fields. The Society’s membership is primarily comprised of gynecologic ...

  [220] BC Cancer SWD1.qxd
      PDF [157,8 KB]  From [h71028.www7.hp.com]  Last viewed: 07.09.2006
British Columbia Cancer Agency improves patient care with distributed storage grid Business need: As diagnostic tools evolve, the file sizes for medical images are growing in tandem. With 30 hospitals and medical centers generating images and sending them to the BC Cancer Agency, the institution needed a better way to store, back up, and protect an immense volume of cancer -related images – and make them instantly available to authorized doctors and clinicians at multiple healthcare facilities. Solution overview: BC Cancer Agency deployed HP StorageWorks Modular Smart Array systems, HP ProLiant servers, and Bycast StorageGRID MultiSite™ software across five facilities to form a distributed storage grid. Working with HP and Bycast, BCCA's IT pros linked the storage infrastructure with the agency's Electronic Medical Records system. This enabled authorized users to acquire ...

  [221] Questions and Answers About Cigar Smoking and Cancer
      PDF [29,6 KB]  From [www.nci.nih.gov]  Last viewed: 07.09.2006
10.16 3/7/00 Page 1 Questions and Answers About Cigar Smoking and Cancer 1. What are the health risks associated with cigar smoking? Scientific evidence has shown that cancers of the oral cavity (lip, tongue, mouth, and throat), larynx, lung, and esophagus are associated with cigar smoking. Furthermore, evidence strongly suggests a link between cigar smoking and cancer of the pancreas. In addition, daily cigar smokers, particularly those who inhale, are at increased risk for developing heart and lung disease. Like cigarette smoking, the risks from cigar smoking increase with increased exposure. For example, compared with someone who has never smoked, smoking only one to two cigars per day doubles the risk for oral and esophageal cancers . Smoking three to four cigars daily can increase the risk of oral cancers to more than eight times the risk for a nonsmoker, while ...

  [222] Cigarette Smoking and Cancer: Questions and Answers
      PDF [35,3 KB]  From [www.nci.nih.gov]  Last viewed: 07.09.2006
10.14 11/4/04 Page 1 Cigarette Smoking and Cancer : Questions and Answers Tobacco use, particularly cigarette smoking, is the single most preventable cause of death in the United States. Cigarette smoking alone is directly responsible for approximately 30 percent of all cancer deaths annually in the United States (1). Cigarette smoking also causes chronic lung disease (emphysema and chronic bronchitis), cardiovascular disease, stroke, and cataracts. Smoking during pregnancy can cause stillbirth, low birthweight, Sudden Infant Death Syndrome (SIDS), and other serious pregnancy complications (2). Quitting smoking greatly reduces a person’s risk of developing the diseases mentioned, and can limit adverse health effects on the developing child. 1. What are the effects of cigarette smoking on cancer rates? Cigarette smoking causes 87 percent of lung cancer deaths (1). Lung cancer ...

  [223] PERSONAL CANCER INDEMNITY/HOSPITAL INTENSIVE CARE PROTECTION Insurance
      PDF [415,8 KB]  From [peoplefirstbenefits.cvgs.net]  Last viewed: 07.09.2006
Capital Insurance Agency, Inc. 1-800-780-3100 Insuring Over 40 Million People Worldwide PERSONAL CANCER INDEMNITY/HOSPITAL INTENSIVE CARE PROTECTION Insurance Without it, no insurance is complete. Form A-19674R2 RC(5/04) Prepared for: State of Florida Employees Page 2 2 CANCER ’S 7 WARNING SIGNALS: C A U T I O N American Cancer Society, 2003 hange in bowel or bladder habits sore that does not heal nusual bleeding or discharge hickening or lump in breast or elsewhere ndigestion or difficulty in swallowing bvious change in wart or mole agging cough or hoarseness If you have a warning signal, see your doctor! T AKE A LOOK AT THE PROTECTION OFFERED ...

  [224] I:\Healthpdf\P_ed\Patient Education\DIS-COND\cancer\specific-types ...
      PDF [108,9 KB]  From [medicalcenter.osu.edu]  Last viewed: 07.09.2006
Cancer of the Colon and Rectum The lower portion of the digestive system is the colon. It is also called the large bowel or large intestine. The colon is the last 5 to 6 feet of the intestine. The last 8 to 10 inches of the colon is the rectum. After food is digested, solid wastes move through the colon and rectum to the anus, where they are passed out of the body. colorectal, detection, rectal Symptoms: Early colorectal cancer often has no symptoms. See your doctor if you have any of these symptoms: C Diarrhea or constipation C Stools that are narrower than usual C Bloating, fullness or cramps C Frequent gas pains C Loss of weight for no reason C Constant tiredness C Blood in or on the stool (bright red or very dark red) C Change in bowel habits ...

  [225] Cancer
      PDF [670,1 KB]  From [www4.dr-rath-foundation.org]  Last viewed: 07.09.2006
3 2 Cellular Health Series: Cancer Matthias Rath, M.D. First Edition, February 2001 Cellular Health Series - Cancer . Copyright 2001 by Matthias Rath, M.D. All rights reserved. Published by MR Publishing, Inc., Santa Clara, CA 95054 No part of this book may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in critical articles or reviews. For information, address: This book is not intended as a substitute for the medical advice of a physician. The reader should regularly consult a physician in matters relating to his or her health and particularly in respect to any symptoms that may require diagnosis or medical attention. The authors and the publisher disclaim responsibility for any adverse effects resulting directly or indirectly from the information contained in this book. ...

  [226] Cancer Facts and Cancer Clusters
      PDF [218,7 KB]  From [www.doh.wa.gov]  Last viewed: 07.09.2006
January 2001 Washington State Department of Health Non-Infectious Conditions Epidemiology Page 1 of 3 Cancer Facts and Cancer Clusters What is a cancer cluster? A cancer cluster is an unusual number of cancers occurring during a specific time period among people who live or work together. The impression that a cancer cluster exists usually begins when someone’s spouse, neighbor, or friend is diagnosed with cancer . This close contact with cancer often brings an awareness of others who have cancer and a desire to answer the question, “Why?” It is not uncommon for people to suspect the cancer cause is a chemical in the environment. Increased awareness about cancer and the search for a cancer cause may lead someone to contact the Department of Health. The following cancer facts might help answer some of your questions about cancer . Cancer Facts Cancer ...

  [227] what is colorectal cancer?
      PDF [199,7 KB]  From [www.ccalliance.org]  Last viewed: 07.09.2006
Colon Cancer Alliance | 175 Ninth Avenue. | New York, NY 10011. | 212.627.7451. | www.CCAlliance.org what is colorectal cancer ? Colorectal cancer included cancers of the colon, rectum, appendix and anus. When abnormal cell growth occurs, a tumor develops. If the cells of a tumor acquire the ability to invade and thus spread into the intestinal wall and to other sites, a malignant or cancerous tumor develops. Most colorectal cancers develop first as colorectal polyps, which are growths inside the colon or rectum that may later become cancerous. incidence + mortality In 2005, an estimated 145,290 new cases of colorectal cancer were diagnosed and 56,290 Americans are expected to die of colorectal cancer in 2005. Colorectal cancer is the second leading killer cancer among men and women combined, second only to lung cancer . risk factors Age | Although ...

  [228] what is the colon cancer alliance?
      PDF [36,0 KB]  From [www.ccalliance.org]  Last viewed: 07.09.2006
Colon Cancer Alliance | 175 Ninth Avenue. | New York, NY 10011. | 212.627.7451. | www.CCAlliance.org what is the colon cancer alliance? what is CCA? The Colon Cancer Alliance (CCA) is an alliance of colon and rectal cancer survivors, their families, caregivers, people with a genetic predisposition to colorectal cancer , and members of the medical community. CCA is the official patient support partner of the National Colorectal Cancer Research Alliance (NCCRA), co-founded by Katie Couric. what is the CCA’s mission? The Colon Cancer Alliance brings the voice of survivors to battle colorectal cancer through patient support, education, research and advocacy. what support services does the CCA offer? The Colon Cancer Alliance offers a variety of support and informational services that include: • Brochures • A series of booklets • An extensive ...

  [229] Tumor Grade: Questions and Answers
      PDF [33,1 KB]  From [www.nci.nih.gov]  Last viewed: 07.09.2006
5.9 5/19/04 Page 1 Tumor Grade: Questions and Answers 1. What is a tumor ? In order to understand tumor grade, it is helpful to know how tumors form. The body is made up of many types of cells. Normally, cells grow and divide to produce new cells in a controlled and orderly manner. Sometimes, however, new cells continue to be produced when they are not needed. As a result, a mass of extra tissue called a tumor may develop. A tumor can be benign (not cancerous) or malignant (cancerous). Cells in malignant tumors are abnormal and divide without control or order. These cancerous cells can invade and damage nearby tissue, and spread to other parts of the body (metastasize). 2. What is tumor grade? Tumor grade is a system used to classify cancer cells in terms of how abnormal they look under a microscope and how quickly the tumor is likely ...

  [230] Colorectal Cancer: The Importance of Prevention and Early ...
      PDF [262,8 KB]  From [cccr.sc.edu]  Last viewed: 07.09.2006
How Common Is Colorectal Cancer ? Colorectal cancer — cancer of the colon or rectum—is the second lead- ing cause of cancer -related deaths in the United States.The American Cancer Society (ACS) estimates that 56,730 Americans will die of colorectal cancer this year. Colorectal cancer is also one of the most commonly diagnosed cancers in the United States; approximately 146,940 new cases will be diagnosed in 2004. Colorectal cancer is the third most common cancer in men and in women. Who Is at Risk? The risk of developing colorectal cancer increases with advancing age, with more than 90% of cases occur- ring in persons aged 50 years or older. Other risk factors include inflamma- tory bowel disease, a personal or family history of colorectal cancer or colorectal polyps, and certain hereditary syndromes.Lifestyle factors ...

  [231] Half of all cancers could be prevented by changes to lifestyle.
      PDF [121,0 KB]  From [info.cancerresearchuk.org]  Last viewed: 07.09.2006
lifestyle & cancer Stay in shape Being overweight or obese increases your risk of several cancers , including cancer of the bowel, kidney, food pipe and womb . It also increases the risk of breast cancer in women who have been through the menopause. Try to maintain a healthy body weight. Balance the energy you take in from food with the energy you burn through physical activity. If you are currently very overweight or have other health problems, talk to your doctor before beginning a weight-loss programme. Take some regular exercise Physical activity has been shown to reduce the risk of bowel cancer and may also reduce the risk of breast cancer . Try to take half an hour of moderate activity at least five times a week. This can be brisk walking, gardening, swimming, cycling, dancing, jogging or similar whatever ...

  [232] SGLS projects- Major diseases- Cancer
      PDF [1134,3 KB]  From [eurosfaire.prd.fr]  Last viewed: 07.09.2006
1 SMEs go LifeSciences – Projects under preparation 2. COMBATING MAJOR DISEASES b) Combating cancer • LSH-2005-2.2.0-1: Broadening the knowledge base on the molecular mechanisms underlying chemotherapy resistance, therapeutic escape, efficacy and toxicity - INTEGRATED PROJECT • LSH-2005-2.2.0-2: Modulation of apoptosis in cancer prevention and therapy – STREP • LSH-2005-2.2.0-3: Innovative diagnostic approaches and novel therapies of childhood cancers – STREP • LSH-2005-2.2.0-4: Innovative research on palliative care in patients with advanced stages of cancer – STREP • LSH-2005-2.2.0-5: Exploring the patient's cancer stem cell as a novel therapeutic target – STREP • LSH-2005-2.2.0-7: Innovative technological approaches for cancer therapy - STREPs dedicated to SMEs • LSH-2005-2.2.0-8: Small-ligand libraries: improved tools for exploration and prospective ...

  [233] of Cancer...
      PDF [4265,7 KB]  From [uccrc.uchicago.edu]  Last viewed: 07.09.2006
I n 1997, the University of Chicago Cancer Research Center (UCCRC) opened a unique resource to offer patients, families, and their friends the empathetic counseling and reliable information that are so critical to the healing process. In June 2004, the UCCRC—in partnership with the American Cancer Society and the Duchossois family— remodeled the Resource Center and moved it to a more accessible and convenient location. These improvements and the ongoing partic- ipation of the American Cancer Society and its Patient Navigation Services™ enable the Center to provide a broad range of resources. The new Cancer Resource Center is a welcoming facility where people can learn about the disease in all of its many manifes- tations, get answers to their most troubling questions, and link with worthwhile com- munity resources. ...

  [234] Open Access cancer journals
      PDF [560,2 KB]  From [www.biomedcentral.com]  Last viewed: 07.09.2006
www.biomedcentral.com/bmccancer editorial@biomedcentral.com Publishes original research articles in all aspects of research relating to cancer , including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, and controlled trials. BMC Cancer is indexed/tracked/covered by PubMed, MEDLINE, BIOSIS and ISI. Editorial Board: Dario Alessi, Mariano Barbacid, Frederick A Beland, Claus Belka, Anton Berns, Andreas Bikfalvi, Maria A Blasco, George J Bosl, Burkhard Brandt, Joan S Brugge, Paolo Bruzzi, Lewis Cantley, Laurent Chauveinc, Carlos Ciudad, Seth J Corey, Jack Cuzick, Peter Daniel, Adam P Dicker, J Michael Dixon, Alexander Dobrovic, Paul A W Edwards, Matthew Ellis, Gerard Evan, Alfio Ferlito, Ian Frazer, Henry S Friedman, Gustav Gaudernack, Arjan W Griffioen, Nick Hastie, Toshio Hirano, Christopher J Kane, Karla Kerlikowske, Masahide Kuroki, Peter Lansdorp, Ralph J Lelle, ...

  [235] Cervical Cancer
      PDF [246,1 KB]  From [www.thegcf.org]  Last viewed: 07.09.2006
A W O M A N ’ S G U I D E Cervical Cancer U NDERSTANDING Page 2 INTRODUCTION 1 CERVICAL CANCER : AN OVERVIEW . 2 WORKING WITH YOUR TREATMENT TEAM 4 TREATMENT6 LIVING WITH CANCER THERAPY. 12 CERVICAL CANCER RESOURCE LIST 16 C ONTENTS Page 3 UNDERSTANDING CERVICAL CANCER 1 I NTRODUCTION You have received a diagnosis of cervical cancer . The amount of infor- mation you receive at the time of diagnosis can feel overwhelming. All at once, you may feel there are questions to be answered, decisions to be made, and so much information to be understood. A team of health care professionals will work with you throughout your treatment process. Each of them has an important job, but the most vital member of the team is you. To play an active role ...

  [236] Cancer
      PDF [673,3 KB]  From [www.stopping-cancer-naturally.org]  Last viewed: 07.09.2006
3 2 Cellular Health Series: Cancer Matthias Rath, M.D. First Edition, February 2001 Cellular Health Series - Cancer . Copyright 2001 by Matthias Rath, M.D. All rights reserved. Published by MR Publishing, Inc., Santa Clara, CA 95054 No part of this book may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in critical articles or reviews. For information, address: This book is not intended as a substitute for the medical advice of a physician. The reader should regularly consult a physician in matters relating to his or her health and particularly in respect to any symptoms that may require diagnosis or medical attention. The authors and the publisher disclaim responsibility for any adverse effects resulting directly or indirectly from the information contained in this book. ...

  [237] 24104_Prostate Cancer
      PDF [460,7 KB]  From [www.uroweb.nl]  Last viewed: 07.09.2006
UPDATE MARCH 2005 European Association of Urology GUIDELINES ON PROSTATE CANCER G. Aus, C.C. Abbou, M. Bolla, A. Heidenreich, H. van Poppel, H-P. Schmid, J.M. Wolff, F. Zattoni Page 2 TABLE OF CONTENTS PAGE 1 BACKGROUND 6 1.1 References 6 2 CLASSIFICATION 7 2.1 Gleason score 7 2.2 References 7 3 RISK FACTORS 8 3.1 References 8 4 SCREENING AND EARLY DETECTION 9 4.1 References 10 5 DIAGNOSIS 11 5.1 Digital rectal examination (DRE) 11 5.2 Prostate-specific antigen (PSA) 11 5.3 Transrectal ultrasonography (TRUS) 12 5.4 Relationship between DRE, PSA, TRUS and prostate cancer (CaP) 12 5.5 Prostate biopsies 12 5.6 References ...

  [238] Human papillomaviruses and cancer
      PDF [380,5 KB]  From [www.sgm.ac.uk]  Last viewed: 07.09.2006
B enign diseases such as hand warts, laryngeal warts, verrucas and numerous other skin lesions can be attributed to infection by one of the 100-plus members of the family of human papillomaviruses (HPV) (Fig. 1). These are small, double-stranded DNA viruses that infect mucosal and cutaneous epithelia through tiny cuts and abrasions that expose cells of the basal layers. The individual virus types are defined by DNA sequence homology, and the resulting phylogenetic trees can also be related to the pathologies induced by specific types (Fig. 2). Papillomaviruses have been found in most higher eukaryotes, with minimal changes to their genomic organization. Scientific study of these small, epitheliotrophic viruses benefited from two important advances in the early 1980s: first, the cloning of HPV genomes into bacterial plasmid vectors; and second, the realization that HPV infection was ...

  [239] Large bowel cancer
      PDF [201,4 KB]  From [info.cancerresearchuk.org]  Last viewed: 07.09.2006
Large Bowel (Colorectal) Cancer Factsheet April 2005 Latest statistics Cancer of the large bowel – which comprises cancers of the colon and rectum - is the third most common cancer in the UK after breast and lung cancer . It is the second most common cause of cancer death, causing 10% of all cancer deaths. As for many other cancers , survival for large bowel cancer has improved in recent years. Incidence In 2001, there were about 34,500 new cases of bowel cancer diagnosed in this country (see Table 1 ), compared with 35,300 cases in 2000. This reflects the random variation affecting the incidence of any cancer from year to year. Table 1: Numbers and incidence rates per 100,000 for bowel cancer , UK, 2001 England Wales Scotland N.Ireland UK Males 15,091 1,083 1,813 513 18,500 Females 13,078 865 ...

  [240] inflammatory breast cancer
      PDF [85,6 KB]  From [www.komen.org]  Last viewed: 07.09.2006
For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. inflammatory breast cancer What is inflammatory breast cancer ? Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer . It is called inflammatory breast cancer because its main symptoms are swelling and redness of the breast. It is a less common form of invasive ductal cancer . Unlike other forms of breast cancer , IBC often lacks a distinct lump or tumor . Instead, it grows in nests or sheets that spread through the breast. IBC is not usually detected by mammograms or ultrasounds unless there is a defined lump. If no lump is present, it can be hard to diagnose. Because IBC cells spread easily to other parts of the body, ...